Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT)

 

 Permissions and Reprints

Abstract

Background: It is the physicians’ task to translate evidence and guidelines into medical strategies for individual patients. Until today, however, there is no formal tool that is instrumental to perform this translation.

Methods: We introduce the analysis of strengths (S) and weaknesses (W) related to therapy with opportunities (O) and threats (T) related to individual patients as a tool to establish an individualized (I) medical strategy (I-SWOT). The I-SWOT matrix identifies four fundamental types of strategy. These comprise “SO” maximizing strengths and opportunities, “WT” minimizing weaknesses and threats, “WO” minimizing weaknesses and maximizing opportunities, and “ST” maximizing strengths and minimizing threats. Each distinct type of strategy may be considered for individualized medical strategies.

Results: We describe four steps of I-SWOT to establish an individualized medical strategy to treat aortic disease. In the first step, we define the goal of therapy and identify all evidence-based therapeutic options. In a second step, we assess strengths and weaknesses of each therapeutic option in a SW matrix form. In a third step, we assess opportunities and threats related to the individual patient, and in a final step, we use the I-SWOT matrix to establish an individualized medical strategy through matching “SW” with “OT”. As an example we present two 30-year-old patients with Marfan syndrome with identical medical history and aortic pathology. As a result of I-SWOT analysis of their individual opportunities and threats, we identified two distinct medical strategies in these patients.

Conclusion: I-SWOT is a formal but easy to use tool to translate medical evidence into individualized medical strategies.

• References

• 1 von Kodolitsch Y, Bernhardt AM, Kölbel T, Detter C, Reichenspurner H, Debus ES. Maximizing therapeutic success: The key concepts of individualized medical strategy (IMS). Cogent Medicine 2015; 2: 1109742 . DOI: 10.1080/2331205X.2015.1109742
  PubMedGoogle Scholar
• 2 von Kodolitsch Y, Overlack C, Kodolitsch K, Bernhardt A, Detter C, Epskamp H. , et al. Strategic thinking as the key to surgical excellence. Medical thought style in the tradition of Kant and Clausewitz. Z Herz- Thorax- Gefäßchir 2013; 27: 282-289 . DOI: 10.1007/s00398-013-1018-y
  CrossrefPubMedGoogle Scholar
• 3 Weihrich H. The TOWS matrix: A tool for situational analysis. . In: Dyson RG. , editor. Strategic Planning: Models and Analytical Techniques: Wiley; 1990. . p. 17-36
  Google Scholar
• 4 Mintzberg H, Ahlstrand BW, Lampel J, Ahlstr B. Strategy safari: a guided tour through the wilds of strategic management. New York: Simon & Schuster Adult Publishing Group; 2005
  Google Scholar
• 5 Ghazinoory S, Abdi M, Azadegan-Mehr M. Swot Methodology: A State-of-the-Art Review for the Past, A Framework for the Future. J Bus Econ Manage 2011; 12: 24-48 . DOI: 10.3846/16111699.2011.555358
  PubMedGoogle Scholar
• 6 Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996; 312: 71-72 . DOI: 10.1136/bmj.312.7023.71
  CrossrefPubMedGoogle Scholar
• 7 Straus S, Haynes B, Glasziou P, Dickersin K, Guyatt G. Misunderstandings, misperceptions, and mistakes. Evid Based Med 2007; 12: 2-3 . DOI: 10.1136/ebm.12.1.2-a
  PubMedGoogle Scholar
• 8 Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H. , et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2873-2926 . DOI: 10.1093/eurheartj/ehu281.
  CrossrefPubMedGoogle Scholar
• 9 Golesworthy T, Lamperth M, Mohiaddin R, Pepper J, Thornton W, Treasure T. The Tailor of Gloucester: a jacket for the Marfan’s aorta. Lancet 2004; 364: 1582 . DOI: 10.1016/S0140-6736(04)17308-X
  CrossrefPubMedGoogle Scholar
• 10 LeMaire S, de la Cruz K, Coselli J. The Thoracoabdominal Aorta in Marfan Syndrome. . In: Bonser RS, Pagano D, Haverich A, Mascaro J. , editors. Controversies in Aortic Dissection and Aneurysmal Disease; Springer London: 2014. . p. 423-434 . DOI: 10.1007/978-1-4471-5622-2_37
  Google Scholar
• 11 von Kodolitsch Y, Robinson P, Berger J. When should surgery be performed in Marfan Syndrome and other connective tissue disorders to protect against type a dissection?. In: Bonser RS, Pagano D, Haverich A, Mascaro J. , editors. Controversies in Aortic Dissection and Aneurysmal Disease; Springer London: 2014. . p. 17-47 . DOI: 10.1007/978-1-4471-5622-2_2
  Google Scholar
• 12 Kim SY, Martin N, Hsia EC, Pyeritz RE, Albert DA. Management of aortic disease in Marfan Syndrome: a decision analysis. Arch Intern Med 2005; 165: 749-755 . DOI: 10.1001/archinte.165.7.749
  CrossrefPubMedGoogle Scholar
• 13 Bernhardt AM, Treede H, Rybczynski M, Sheikzadeh S, Kersten JF, Meinertz T. , et al. Comparison of aortic root replacement in patients with Marfan syndrome. Eur J Cardiothorac Surg 2011; 40: 1052-1057 . DOI: 10.1016/j.ejcts.2011.02.018
  PubMedGoogle Scholar
• 14 Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med 1994; 330: 1335-1341 . DOI: 10.1056/NEJM199405123301902
  CrossrefPubMedGoogle Scholar
• 15 Groenink M, den Hartog AW, Franken R, Radonic T, de Waard V, Timmermans J. , et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 2013; 34: 3491-3500 . DOI: 10.1093/eu-rheartj/eht334
  CrossrefPubMedGoogle Scholar
• 16 Treasure T, Takkenberg JJ, Golesworthy T, Rega F, Petrou M, Rosendahl U. , et al. Personalised external aortic root support (PEARS) in Marfan syndrome: analysis of 1-9 year outcomes by intention-to-treat in a cohort of the first 30 consecutive patients to receive a novel tissue and valve-conserving procedure, compared with the published results of aortic root replacement. Heart 2014; 100: 969-975 . DOI: 10.1136/heartjnl-2013-304913
  CrossrefPubMedGoogle Scholar
• 17 David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg 1992; 103: 617-621 . PMID: 1532219
  CrossrefPubMedGoogle Scholar
• 18 Hilgenberg AD, Mora BN. Composite aortic root replacement with a bovine pericardial valve conduit. Ann Thorac Surg 2003; 75: 1338-1339 . DOI: 10.1016/S0003-4975(02)04510-1
  CrossrefPubMedGoogle Scholar
• 19 Bentall H, De Bono A. A technique for complete replacement of the ascending aorta. Thorax 1968; 23: 338-339 . DOI: 10.1136/thx.23.4.338
  CrossrefPubMedGoogle Scholar
• 20 Ades L. Guidelines for the diagnosis and management of Marfan syndrome. Heart Lung Circ 2007; 16: 28-30 . DOI: 10.1016/j.hlc.2006.10.022
  CrossrefPubMedGoogle Scholar
• 21 Silversides CK, Kiess M, Beauchesne L, Bradley T, Connelly M, Niwa K. , et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol 2010; 26: e80-97 . DOI: 10.1016/S0828-282X(10)70355-X
  CrossrefPubMedGoogle Scholar
• 22 Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey Jr DE. , et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121: e266-369 . DOI: 10.1161/CIR.0b013e3181d4739e
  PubMedGoogle Scholar
• 23 Meijboom LJ, Timmermans J, Zwinderman AH, Engelfriet PM, Mulder BJ. Aortic root growth in men and women with the Marfan’s syndrome. Am J Cardiol 2005; 96: 1441-1444 . DOI: 10.1016/j.amjcard.2005.06.094
  CrossrefPubMedGoogle Scholar
• 24 Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G. , et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268 . DOI: 10.1093/eurheartj/ehl428
  PubMedGoogle Scholar